These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6296183)

  • 1. Reciprocal changes in active and inactive renin after converting enzyme inhibition in normal man.
    Goldstone R; Horton R; Carlson EJ; Hsueh WA
    J Clin Endocrinol Metab; 1983 Feb; 56(2):264-8. PubMed ID: 6296183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that the beta-adrenergic system and prostaglandins stimulate renin release through different mechanisms.
    Hsueh WA; Goldstone R; Carlson EJ; Horton R
    J Clin Endocrinol Metab; 1985 Sep; 61(3):399-403. PubMed ID: 2991316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a dual action of converting enzyme inhibitor on blood pressure in normal man.
    Goldstone R; Martin K; Zipser R; Horton R
    Prostaglandins; 1981 Oct; 22(4):587-98. PubMed ID: 6275456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primacy of the renin-angiotensin system in mediating the aldosterone response to sodium restriction.
    Swartz SL; Williams GH; Hollenberg NK; Dluhy RG; Moore TJ
    J Clin Endocrinol Metab; 1980 Jun; 50(6):1071-4. PubMed ID: 6989849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of captopril-induced renin release by angiotensin II.
    Mersey JH; Ceballos L; Swartz S
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):575-9. PubMed ID: 2447408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of captopril and aprotinin on inactive renin.
    Sealey JE; Overlack A; Laragh JH; Stumpe KO; Atlas SA
    J Clin Endocrinol Metab; 1981 Sep; 53(3):626-30. PubMed ID: 6167591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of angiotensin-converting enzyme inhibition on prolactin responses in normal and hyperprolactinemic subjects.
    Anderson PW; Malarkey WB; Salk J; Kletsky OA; Hsueh WA
    J Clin Endocrinol Metab; 1989 Sep; 69(3):518-22. PubMed ID: 2503532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Conversion of inactive renin to active renin following acute angiotensin converting enzyme inhibition in essential hypertension and renovascular hypertension].
    Kutkuhn B; Chlebowski H; Hollenbeck M; Grabensee B
    Z Kardiol; 1989 Mar; 78(3):204-10. PubMed ID: 2652907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of inhibition of converting enzyme on inactive renin in the circulation of salt-replete and salt-deplete normal subjects.
    Millar JA; Hammat MT; Johnston CI
    J Endocrinol; 1980 Aug; 86(2):329-35. PubMed ID: 6253587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active and inactive renin after a single dose of captopril in hypertensive patients.
    Glorioso N; Dessi Fulgheri P; Madeddu P; Fois G; Palermo M; Cocco F; Dettori S; Rappelli A
    Am J Cardiol; 1982 Apr; 49(6):1552-4. PubMed ID: 7041596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of angiotensin I converting enzyme inhibitor, SQ 14225, on renin production and release.
    Saruta T; Eguchi T; Yasui T; Nagahama S; Nakamura R; Kato E
    Nephron; 1981; 29(5-6):265-9. PubMed ID: 6172718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of moderate to severe hypertensive patients with an orally active converting-enzyme inhibitor.
    Prins EJ; Donker AJ; Hoorntje SJ; Leenen FH; van der Hem GK
    Proc Eur Dial Transplant Assoc; 1979; 16():603-9. PubMed ID: 232914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between aldosterone and bradykinin.
    Mersey JH; Williams GH; Hollenberg NK; Dluhy RG
    Circ Res; 1977 May; 40(5 Suppl 1):I84-8. PubMed ID: 870233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new principle in long-term treatment of essential hypertension: angiotensin-converting enzyme inhibition (author's transl)].
    Overlack A; Stumpe KO; Heck I; Krück F
    Dtsch Med Wochenschr; 1980 Apr; 105(15):505-9. PubMed ID: 6244920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.